MAGAZINES INTEREST WOMEN

Brand Owner (click to sort) Address Description
CHATELAINE SJC HERITAGE INC. 15 BENTON ROAD TORONTO ON M6M 3G2 Canada MAGAZINES OF INTEREST TO WOMEN;CHATE LAINE;THE ENGLISH TRANSLATION OF THE WORD CHATELAINE IN THE MARK IS MISTRESS OF A CASTLE OR MANOR.;
CHATELAINE 2376068 ONTARIO INC. 15 BENTON ROAD TORONTO ON M6M3G2 Canada MAGAZINES OF INTEREST TO WOMEN;CHATE LAINE;THE ENGLISH TRANSLATION OF THE WORD CHATELAINE IN THE MARK IS MISTRESS OF A CASTLE OR MANOR.;
CHATELAINE 2373904 ONTARIO INC. 15 BENTON ROAD TORONTO ON M6M3G2 Canada MAGAZINES OF INTEREST TO WOMEN;CHATE LAINE;THE ENGLISH TRANSLATION OF THE WORD CHATELAINE IN THE MARK IS MISTRESS OF A CASTLE OR MANOR.;
CHATELAINE ROGERS MEDIA INC. 9th Floor 333 Bloor Street East Toronto, Ontario M4W1G9 Canada MAGAZINES OF INTEREST TO WOMEN;CHATE LAINE;THE ENGLISH TRANSLATION OF THE WORD CHATELAINE IN THE MARK IS MISTRESS OF A CASTLE OR MANOR.;
MS. LIBERTY MEDIA FOR WOMEN 1600 WILSON BOULEVARD, #801 ARLINGTON VA 22209 MAGAZINES OF INTEREST TO WOMEN;MISS, MISSES;
MS. MacDonald Communciations Corporation 230 Park Avenue New York NY 10169 MAGAZINES OF INTEREST TO WOMEN;MISS, MISSES;
MS. FAIRFAX PUBLICATIONS (US) LTD. ONE TIMES SQUARE NEW YORK NY 10036 MAGAZINES OF INTEREST TO WOMEN;MISS, MISSES;
SWIRV MAGAZINE Donna Michelle Ballard 3480 Andrews Drive #204 Pleasanton CA 94588 magazines of interest to women, the home, food and beauty and personal care;magazine;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. Described are methods for protecting the female reproductive system against natural and artificial insults by administering to women a composition comprising an agent that antagonizes one or more acid sphingomyelinase (ASMase) gene products. Specifically, methods disclosed herein serve to protect women's germline from damage resulting from cancer therapy regimens including chemotherapy or radiotherapy. In one aspect, the method preserves, enhances, or revives ovarian function in women, by administering to women a composition containing sphingosine-1-phosphate, or an analog thereof. Also disclosed are methods to prevent or ameliorate menopausal syndromes and to improve in vitro fertilization techniques.